Hainan Huluwa Pharmaceutical Group (605199.SH) appoints Zhang Mingrui as the general manager.

Hainan Huluwa Pharmaceutical Group (605199.SH) has announced that the board of directors recently received a resignation report from Ms. Liu Jingping. In order to better fulfill the duties of the chairman, she will focus more on the company's strategic planning, governance and other aspects, and has applied to resign from the position of general manager. After resigning as general manager, Ms. Liu Jingping will continue to serve as chairman of the company, chairman of the strategic and ESG committee, and member of the nomination committee. The company held the first interim meeting of the third board of directors in 2025 on March 4, 2025, and approved the proposal to appoint Ms. Zhang Mingrui as the general manager of the company. Her term will start from the date of approval by the board of directors and end on the expiration date of the third board of directors.